Trial Profile
Saving residual kidney function among haemodialysis patients receiving irbesartan - a double blind randomised study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Mar 2016
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Left ventricular hypertrophy
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms SAFIR
- 06 May 2013 New trial record